TGFB1 and neoplasm: Results from TGF-β gene expression in the tumor microenvironment showed that immunization with cell lysate + GM2 mg, cell lysate + GM4 mg, and lysate vaccine significantly decreased in comparison to the PBS group (p = 0.0079).